semaglutide aion may be associated with non-arteritic ischemic optic neuropathy (NAION) | Eye Care Network Semaglutide and Nonarteritic Anterior Ischemic

More serious but less common safety considerations observed across this drug class include a potential risk of pancreatitis, gallbladder-related conditions (such as gallstones/cholelithiasis), and based on animal studies a theoretical concern regarding thyroid C-cell tumours, though this has not been confirmed in human trials

Carnitine has been recognized as a nutritional supplement in cardiovascular disease and there is increasing evidence that carnitine supplementation may be beneficial in treating obesity, improving glucose intolerance and total energy expenditure

When managing side effects from GLP-1 medications, traditional digestive advice often does not apply

Coverage for compounded GLP-1 medications varies by plan, and many insurance plans may not cover them